Mara R Rubinstein Selected Research

Mara R Rubinstein Research Topics

2	Neoplasms (Cancer) 02/2023 - 01/2023
1	Breast Neoplasms (Breast Cancer) 02/2023
1	Colitis 01/2023
1	Carcinogenesis 01/2023
1	Inflammation (Inflammations) 01/2023
1	Colitis-Associated Neoplasms 01/2023
1	Insulin Resistance 11/2022
1	Weight Gain 11/2022
1	Glucose Intolerance 11/2022
1	Cognitive Dysfunction 11/2022
1	Intracranial Thrombosis (Cerebral Thrombosis) 01/2019
1	Ischemic Stroke 01/2019
1	Middle Cerebral Artery Infarction (Middle Cerebral Artery Syndrome) 01/2019
1	Stroke (Strokes) 01/2019
1	Thrombosis (Thrombus) 01/2019

1	Histamine (Histamine Dihydrochloride)FDA Link 02/2023
1	MicellesIBA 02/2023
1	Paclitaxel (Taxol)FDA LinkGeneric 02/2023
1	Nanoparticle Drug Delivery SystemIBA 02/2023
1	Dextrans (Dextran)FDA Link 01/2023
1	Doxorubicin (Adriamycin)FDA LinkGeneric 01/2023
1	Interleukin-6 (Interleukin 6)IBA 01/2023
1	CytokinesIBA 01/2023
1	AzoxymethaneIBA 01/2023
1	Sulfonic AcidsIBA 01/2023
1	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 01/2023
1	sodium sulfate (sodium bisulfate)FDA LinkGeneric 01/2023
1	Brain-Derived Neurotrophic Factor (BDNF)IBA 11/2022
1	CholesterolIBA 11/2022
1	Glucose (Dextrose)FDA LinkGeneric 11/2022
1	Messenger RNA (mRNA)IBA 11/2022
1	Proteins (Proteins, Gene)FDA Link 01/2019
1	IntegrinsIBA 01/2019
1	PhosphatidylserinesIBA 01/2019
1	Coloring Agents (Dyes)IBA 01/2019
1	Annexin A1IBA 01/2019
1	CalciumIBA 01/2019
1	Thromboxane B2IBA 01/2019
1	Thrombin FDA Link 01/2019

1	Drug Therapy (Chemotherapy) 02/2023
1	Therapeutics 01/2023